One type of anticipatory timing relies on memories from past experiences. The other on rhythm. Both are critical to our ability to navigate and enjoy the world, and UC Berkeley scientists have found they are handled in two different parts of the brain.
A team of neurologists at Georgetown University Medical Center has found that inhibiting the USP13 molecule may be a therapeutic target in Parkinson's disease and other similar forms of neurodegeneration.
A high-tech form of brain surgery that replaces scalpels with sound waves improved quality of life for people with Parkinson's disease that has resisted other forms of treatment, a new study has found.
A study from a group of Massachusetts General Hospital investigators may reduce the concern that elevating levels of urate, an approach being investigated to treat several neurodegenerative disorders, could increase the risk of hypertension.
University of Tsukuba researchers revealed the importance of the brain's dopaminergic system for inhibiting already-planned actions. They trained monkeys to redirect their gaze towards targets newly presented on a screen, apart from when presented with signals to avoid such redirection. Simultaneous analysis showed that the activity of dopaminergic neurons correlated with successful refusal to redirect gaze to a new target. These findings could aid the development of treatments for diseases with impaired inhibition like Parkinson's.
Researchers at the Faculty of Medicine, University of Helsinki, make an unexpected and vital contribution to an international collaborative effort in Parkinson's disease research.
Singing may provide benefits beyond improving respiratory and swallow control in people with Parkinson's disease, according to new data from Iowa State University researchers. The results from the pilot study revealed improvements in mood and motor symptoms, as well as reduced physiological indicators of stress.
A new study out of the Krembil Brain Institute, part of the Krembil Research Institute, suggests drinking coffee may protect you against developing both Alzheimer's and Parkinson's disease.
A new gene therapy can turn certain brain glial cells into functioning neurons, which in turn could help repair the brain after a stroke or during neurological disorders like Alzheimer's or Parkinson's diseases.
Rutgers scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer's and Parkinson's diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries. Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete differentiation of cells and limited growth of neural connections.